Recombinant microorganism producing 1,3-diaminopropane and method for producing 1,3-diaminopropane using the same

Abstract

The present disclosure relates to a recombinant microorganism producing 1,3-diaminopropane, and a method for producing 1,3-diaminopropane using the same, and specifically, to a recombinant microorganism producing 1,3-diaminopropane into which genes encoding an enzyme involved in a metabolic pathway of 1,3-diaminopropane, dat and ddc, are introduced, and a method for producing 1,3-diaminopropane using the same. When the recombinant microorganism producing the 1,3-diaminopropane according to the present disclosure is used, 1,3-diaminopropane may be mass-produced to be industrially useful in various fields such as pharmaceutical products, agricultural products, fibers for clothing, etc.

Claims

1. A recombinant microorganism producing 1,3-diaminopropane in which a gene encoding 2-ketoglutarate 4-aminotransferase (dat) and a gene encoding 2,4-diaminobutanoate decarboxylase (ddc) are introduced into a microorganism having an ability of producing aspartate-4-semialdehyde (ASA), wherein the recombinant microorganism comprises further mutation of base sequence of a gene encoding aspartokinase I and/or a gene encoding aspartokinase III to remove feedback inhibiting production of 1,3-diaminopropane, wherein the mutation of base sequence of a gene encoding aspartokinase I is the substitution of C of 1034th base sequence with T, and the mutation of base sequence of a gene encoding aspartokinase III is the substitution of C of 1055th base sequence with T, wherein the recombinant microorganism producing the 1,3-diaminopropane comprises further variation selected from the group consisting of: (i) over-expression of a gene encoding aspartate aminotransferase; and (ii) deletion of a gene encoding 6-phosphofructokinase I.

2. The recombinant microorganism of claim 1, wherein the microorganism having an ability of producing aspartate-4-semialdehyde (ASA) is selected from the group consisting of Escherichia genus, Bacillus genus, Corynebacterium genus, Pichia genus, Pseudomonas genus and Saccharomyces genus.

3. The recombinant microorganism of claim 1, wherein the over-expression comprises (i) substitution of a promoter of a gene encoding phosphoenolpyruvate carboxylase and/or the gene encoding aspartate aminotransferase with a strong promoter or (ii) introduction of an expression vector having a gene encoding phosphoenolpyruvate carboxylase and/or the gene encoding aspartate aminotransferase, and the strong promoter.

4. The recombinant microorganism of claim 3, wherein the strong promoter is selected from the group consisting of a trc promoter, a tac promoter, a T7promoter, a lac promoter, and a trp promoter.

5. The recombinant microorganism of claim 1, wherein the gene encoding the 2-ketoglutarate 4-aminotransferase (dat) and the gene encoding 2,4-diaminobutanoate decarboxylase (ddc) are derived from Acinetobacter baumannii.

6. The recombinant microorganism of claim 1, wherein the 2-ketoglutarate 4-aminotransferase has the amino acid sequence of SEQ ID NO: 1.

7. The recombinant microorganism of claim 1, wherein the 2,4-diaminobutanoate decarboxylase has the amino acid sequence of SEQ ID NO: 2.

8. The recombinant microorganism of claim 1, wherein the gene encoding the 2-ketoglutarate 4-aminotransferase has the base sequence of SEQ ID NO: 3 or SEQ ID NO: 4.

9. The recombinant microorganism of claim 1, wherein the gene encoding the 2,4-diaminobutanoate decarboxylase has the base sequence of SEQ ID NO: 5 or SEQ ID NO: 6.

10. The recombinant microorganism of claim 1, wherein the gene encoding the 2-ketoglutarate 4-aminotransferase (dat) and the gene encoding 2,4-diaminobutanoate decarboxylase (ddc) are introduced in the recombinant microorganism in a form in which the genes are inserted in one vector.

11. The recombinant microorganism of claim 10, wherein the vector has a strong promoter.

12. The recombinant microorganism of claim 11, wherein the strong promoter is selected from the group consisting of a trc promoter, a tac promoter, a T7 promoter, a lac promoter, and a trp promoter.

13. A method for producing 1,3-diaminopropane comprising: (a) producing 1,3-diaminopropane by culturing the recombinant microorganism of claim 1; and (b) recovering the produced 1,3-diaminopropane.

Description

DESCRIPTION OF DRAWINGS

(1) FIG. 1 is a schematic diagram showing a 1,3-diaminopropane biosynthesis pathway.

(2) FIG. 2 shows a p15DD plasmid in which dat and ddc genes are inserted.

(3) FIG. 3 shows a p15DD.sup.opt plasmid in which codon optimized dat.sup.opt and dde.sup.opt genes are inserted.

(4) FIG. 4 shows a p15DD.sup.optppc plasmid in which codon optimized dat.sup.opt and dde.sup.opt genes, and ppc gene are inserted.

(5) FIG. 5 shows a p15DD.sup.optpaspC plasmid in which codon optimized dat.sup.opt and dde.sup.opt genes, a tac promoter, and an aspC gene are inserted.

BEST MODE

(6) In the present disclosure, a recombinant microorganism for producing 1,3-diaminopropane was produced by introducing a gene encoding an enzyme involved in a metabolic pathway of 1,3-diaminopropane into a microorganism that does not produce the 1,3-diaminopropane to express the gene, and it was confirmed that the 1,3-diaminopropane was produced by using the same.

(7) The metabolic pathway of 1,3-diaminopropane of the present disclosure consists of 2-ketoglutarate 4-aminotransferase and 2,4-diaminobutanoate decarboxylase. The 2-ketoglutarate 4-aminotransferase is an enzyme converting aspartate-4-semialdehyde into 2,4-diaminobutanoate, and the 2,4-diaminobutanoate decarboxylase is an enzyme converting 2,4-diaminobutanoate into 1,3-diaminopropane.

(8) In an aspect of the present disclosure, the present disclosure relates to a recombinant microorganism producing 1,3-diaminopropane in which a gene encoding 2-ketoglutarate 4-aminotransferase (dat) and a gene encoding 2,4-diaminobutanoate decarboxylase (ddc) are introduced into a microorganism having an ability of producing aspartate-4-semialdehyde (ASA).

(9) In the present disclosure, the microorganism may be exemplified by Escherichia genus, Bacillus genus, Corynebacterium genus, Pichia genus, Pseudomonas genus, Saccharomyces genus, etc., preferably, may be Escherichia genus microorganism, and the most preferably, E. coli. In particular, the E. coli is an industrially and largely used strain, and has an advantage of being easily industrialized since genetic information and culture condition are known.

(10) In an exemplary embodiment of the present disclosure, in order to produce the microorganism producing 1,3-diaminopropane, a recombinant plasmid p15D was constructed by inserting a fragment of dat which is a gene encoding 2-ketoglutarate 4-aminotransferase derived from Acinetobacter baumannii in a pTac15k plasmid performing strong gene expression with a tac promoter, and then, a fragment of ddc which is a gene encoding 2,4-diaminobutanoate decarboxylase derived from Acinetobacter baumannii was inserted in the p15D to construct a recombinant plasmid p15DD.

(11) In another exemplary embodiment of the present disclosure, in order to improve production capacity of 1,3-diaminopropane in E. coli, a recombinant plasmid p15D.sup.opt was constructed by inserting a fragment of dat.sup.opt which is a gene encoding 2-ketoglutarate 4-aminotransferase optimized in codon of the E. coli in the pTac15k plasmid performing strong gene expression with the tac promoter, and then, a fragment of dde.sup.opt which is a gene encoding 2,4-diaminobutanoate decarboxylase optimized in codon of the E. coli was inserted in the p15D.sup.opt to construct a recombinant plasmid p15DD.sup.opt.

(12) In still another exemplary embodiment of the present disclosure, in order to improve production capacity of the 1,3-diaminopropane by removing feedback inhibiting production of 1,3-diaminopropane in E. coli, a recombinant microorganism in which C of 1034.sup.th base sequence of a gene encoding aspartokinase I is substituted with T, or C of 1055.sup.th base sequence of a gene encoding aspartokinase III is substituted with T, was produced. Further, in order to improve the production capacity of the 1,3-diaminopropane by increasing pool of oxaloacetate (OAA) or aspartate (L-ASP) in the recombinant microorganism, a recombinant microorganism in which ppc which is a gene encoding phosphoenolpyruvate carboxylase and/or aspC which is a gene encoding aspartate aminotransferase, was over-expressed with a strong promoter, trc or tac, was produced. In addition, in order to improve production capacity of the 1,3-diaminopropane by increasing pool of NADPH, a recombinant microorganism in which a gene (pfkA) encoding 6-phosphofructokinase I was further deleted from the above recombinant microorganism, was produced.

(13) In the present disclosure, the microorganism producing the 1,3-diaminopropane may comprise further variation selected from the group consisting of (i) mutation of base sequence of a gene encoding aspartokinase I and/or a gene encoding aspartokinase III to remove feedback inhibiting production of 1,3-diaminopropane; (ii) over-expression of a gene encoding phosphoenolpyruvate carboxylase and/or a gene encoding aspartate aminotransferase; and (iii) deletion of a gene encoding 6-phosphofructokinase I, wherein it is preferred that the mutation of the base sequence of the gene encoding the aspartokinase I includes substitution of 1034.sup.th base sequence C with T, or the mutation of the base sequence of the gene encoding the aspartokinase III includes substitution of 1055.sup.th base sequence C with T, but the mutation is not limited thereto.

(14) In the present disclosure, the over-expression may comprise substitution of a promoter of the gene encoding phosphoenolpyruvate carboxylase and/or the gene encoding aspartate aminotransferase with a strong promoter or may comprise introduction of an expression vector containing the gene encoding phosphoenolpyruvate carboxylase and/or the gene encoding aspartate aminotransferase, and the strong promoter, but the over-expression is not limited thereto.

(15) In the present disclosure, the strong promoter may be selected from the group consisting of a trc promoter, a tac promoter, a T7 promoter, a lac promoter, and a trp promoter.

(16) In the present disclosure, the gene encoding the 2-ketoglutarate 4-aminotransferase (dat) and the gene encoding 2,4-diaminobutanoate decarboxylase (ddc) are preferably derived from the Acinetobacter baumannii, but the present disclosure is not limited thereto. Specifically, even though the gene is derived from various different microorganisms encoding the enzyme involved in the metabolic pathway of 1,3-diaminopropane, the gene is not limited as long as it is introduced into a host microorganism and expressed to have the same enzyme activity.

(17) In the present disclosure, the 2-ketoglutarate 4-aminotransferase may have an amino acid sequence of SEQ ID NO: 1, and the 2,4-diaminobutanoate decarboxylase may have an amino acid sequence of SEQ ID NO: 2.

(18) In the present disclosure, the gene encoding the 2-ketoglutarate 4-aminotransferase may have a base sequence of SEQ ID NO: 3 or SEQ ID NO: 4, and the gene encoding the 2,4-diaminobutanoate decarboxylase may have a base sequence of SEQ ID NO: 5 or SEQ ID NO: 6.

(19) In still another exemplary embodiment of the present disclosure, in order to improve production capacity of the 1,3-diaminopropane by over-expressing the ppc or the aspC, a recombinant plasmid p15DD.sup.optppc was constructed by inserting the ppc in the p15DD.sup.opt, and then, p15DD.sup.optpaspC was constructed by positioning the aspC gene behind the tac promoter in the p15DD.sup.opt.

(20) In the present disclosure, the gene encoding the 2-ketoglutarate 4-aminotransferase (dat) and the gene encoding 2,4-diaminobutanoate decarboxylase (ddc) are introduced in the recombinant microorganism in a form in which the genes are inserted in one vector, but the present disclosure is not limited thereto. Specifically, any one or both of the genes encoding the enzyme involved in the metabolic pathway of 1,3-diaminopropane may be directly introduced onto chromosome of the host microorganism, and may be introduced into the host microorganism in a form of a recombinant vector produced by inserting any one or both of the genes in an expression vector.

(21) In the present disclosure, the strong promoter contained in the vector may be selected from the group consisting of a trc promoter, a tac promoter, a T7 promoter, a lac promoter, and a trp promoter, and specifically, the tac promoter is preferred. However, the strong promoter is not limited thereto.

(22) In the present disclosure, the vector means a DNA construct including DNA sequences operably linked to an appropriate control sequence capable of expressing DNA in an appropriate host. The vector may be a plasmid, phage particles, or simply be a potential genomic insert. When the vector is transformed into the appropriate host, the vector may replicate and function regardless of the host genome, or in some cases, may be incorporated with the genome itself. The plasmid is the most generally used form of the vector at present, such that the plasmid and the vector used herein are sometimes interchangeably used. In view of a purpose of the present disclosure, it is preferable to use a plasmid vector. A typical plasmid vector which is usable for the purpose has a structure including (a) a replication origin for effective replication so as to include hundreds of plasmid vectors per a host cell, (b) an antibiotic resistance gene capable of selecting the host cell transformed with the plasmid vector, and (c) a restriction enzyme cleavage site at which a foreign DNA fragment is able to be inserted. Even though the appropriate restriction enzyme cleavage site does not exist, ligation between the vector and the foreign DNA may be easily obtained by using a synthetic oligonucleotide adaptor or a linker according to general methods.

(23) After the ligation, the vector is required to be transformed into the appropriate host cell. The transformation may be easily achieved by using a calcium chloride method described in document (Sambrook, et al., supra, Section 1.82). Alternatively, electroporation (Neumann, et al., EMBO J., 1:841, 1982) may also be used for transformation of these cells.

(24) As known in the art, in order to increase the expression level of the transfected gene in the host cell, the corresponding gene needs to be operably linked to transcriptional and translational expression control sequences that exert function in the selected expression host. Preferably, the expression control sequence and the corresponding gene are included in one recombinant vector including a bacterial selectable marker and a replication origin together.

(25) The host cell transformed by the above-described recombinant vector forms a still another aspect of the present disclosure. The term transformation used herein means that DNA is replicable as a chromosomal extrinsic factor or by chromosomal integration completion by introducing DNA into the host. A method for transformation includes any method in which nucleic acids are introduced into an organism, a cell, a tissue, or an organ, and may be performed by selecting an appropriate standard technology depending on the host cell as known in the art. The method for transformation includes electroporation, protoplast fusion, calcium phosphate (CaPO.sub.4) precipitation, calcium chloride (CaCl.sub.2) precipitation, stirring with silicon carbide fibers, agrobacterium-mediated transformation, PEG, dextran sulfate, lipofectamine and dryness/inhibition-mediated transformation; however, the present disclosure is not limited thereto. The host cell of the present disclosure may be a prokaryotic cell or a eukaryotic cell. In addition, a host in which an introduction efficiency of DNA is high, and an expression efficiency of the introduced DNA is high is generally used. Cells of known eukaryotic and prokaryotic hosts such as escherichia coli, pseudomonas, bacillus, streptomyces, fungi, and yeast, insect cells such as Spodoptera frugiperda (SF9), animal cells such as CHO and mouse cells, African green monkey cells such as COS 1, COS 7, BSC 1, BSC 40, and BMT 10, and tissue-cultured human cells are examples of host cells to be usable.

(26) It should be understood that all vectors do not equally exert function in expressing DNA sequences of the present disclosure. Similarly, all of the host cells do not exert the function equally to the same expression system. However, those skilled in the art are able to have an appropriate selection among various vectors, expression control sequences, and hosts without departing from the scope of the present disclosure without undue experimental burden. For example, the host needs to be considered in selecting the vector, which is because the host is required to replicate in the host. Replication numbers of the vector, ability to control the replication numbers, and other proteins encoded by the vector, for example, expression of an antibiotic marker are also required to be considered. In selecting the expression control sequence, a number of factors need to be considered. For example, relative strength of the sequence, control possibility, and compatibility with the DNA sequences of the present disclosure, etc., are required to be considered with respect to a possible secondary structure. A single cell host is required to be selected in consideration of factors such as the selected vector, toxicity of a product encoded by the DNA sequence of the present disclosure, secretion property, ability to precisely fold the protein, culture and fermentation requirements, easiness in purifying the product encoded by the DNA sequence of the present disclosure from the host, etc. Within the scope of these variables, those skilled in the art may select various combinations of vectors/expression control sequences/hosts capable of fermenting the DNA sequences of the present disclosure or expressing the DNA sequences in large scale animal culture. As a screening method when cloning cDNA of an NSP protein by expression cloning, a binding method, a panning method, a film emulsion method, etc., may be applied.

(27) In still another exemplary embodiment of the present disclosure, it was confirmed that when culturing the recombinant microorganism into which dat (the gene encoding 2-ketoglutarate 4-aminotransferase) and ddc (the gene encoding 2,4-diaminobutanoate decarboxylase) were introduced, and the recombinant microorganism into which dat.sup.opt (the gene encoding 2-ketoglutarate 4-aminotransferase optimized in codon of the E. coli) and ddc.sup.opt (the gene encoding 2,4-diaminobutanoate decarboxylase optimized in codon of the E. coli) were introduced, 65 mg/L and 144 mg/L of 1,3-diaminopropane were produced, respectively. In addition, it was confirmed that when culturing the recombinant microorganism into which the dat and ddc were introduced and in which C of 1034.sup.th base sequence of the gene encoding aspartokinase I is substituted with T, or C of 1055.sup.th base sequence of the gene encoding aspartokinase III is substituted with T, and the recombinant microorganism into which the dat.sup.opt and dde.sup.opt were introduced, 89 mg/L and 175 mg/L of 1,3-diaminopropane were produced, respectively. Further, it was confirmed that when culturing a recombinant microorganism in which a promoter of ppc (the gene encoding phosphoenolpyruvate carboxylase) was substituted with trc so as to increase a pool of oxaloacetate, and culturing a recombinant microorganism in which a promoter of aspC (the gene encoding aspartate aminotransferase) was substituted with trc so as to increase a pool of aspartate, in the above recombinant microorganism, 182 mg/L and 282 mg/L of 1,3-diaminopropane were produced, respectively. Further, it was confirmed that when culturing a recombinant microorganism in which pfkA (the gene encoding phosphofructokinase I) was deleted from the recombinant microorganism in which the promoter of ppc and the promoter of aspC were substituted with trc so as to increase a pool of NADPH, in the above recombinant microorganism, 680 mg/L of 1,3-diaminopropane were produced. In addition, it was confirmed that when culturing a recombinant microorganism in which the ppc was over-expressed on the vector, and a recombinant microorganism in which the aspC was over-expressed on the vector in order to increase the pool of the oxaloacetate or the pool of the aspartate, in the recombinant microorganism from which pfkA was deleted, 1391 mg/L and 1349 mg/L of 1,3-diaminopropane were produced, respectively.

(28) In another aspect of the present disclosure, the present disclosure relates to a method for producing a recombinant microorganism producing 1,3-diaminopropane including introducing a gene encoding 2-ketoglutarate 4-aminotransferase (dat) and a gene encoding 2,4-diaminobutanoate decarboxylase (ddc) into a microorganism having an ability of producing aspartate-4-semialdehyde (ASA).

(29) In still another aspect of the present disclosure, the present disclosure relates to a method for producing 1,3-diaminopropane including: (a) producing 1,3-diaminopropane by culturing the recombinant microorganism; and (b) recovering the produced 1,3-diaminopropane.

(30) Hereinafter, the present disclosure is described in detail with reference to Examples. These Examples are only provided to specifically explain the present disclosure, and it will be obvious to those skilled in the art that the technical scope of the present disclosure is not construed to be limited to these Examples.

EXAMPLE 1

Construction of Vector Containing Gene Involved in the Production of 1,3-Diaminopropane

(31) 1-1: Construction of p15DD Vector Containing dat and ddc

(32) PCR was performed with DNA (SEQ ID NO: 3) of 2-ketoglutarate 4-aminotransferase (dat) derived from Acinetobacter baumannii ATCC 19606 strain as a template, and primers of SEQ ID NOs: 9 and 10. The DNA was heated for 2 minutes at 95 C., followed by denaturation for further 30 seconds. The DNA was combined with the primer for 40 seconds at 55 C., and polymerized for 50 seconds at 72 C. The process from the DNA denaturation to polymerization was repeated 30 times, and the obtained product was maintained for 10 minutes at 72 C., and then, the temperature was lowered to 4 C. to terminate the PCR.

(33) Next, the dat fragment and a pTac15k plasmid (p15A origin, low copies, Km.sup.R, KAISTMBEL labstock) performing strong gene expression with a tac promoter were treated with restriction enzymes (EcoRI and KpnI), and then, treated with T4 DNA ligase to bind the dat fragment and the pTac15k plasmid cut with the restriction enzymes, thereby constructing a recombinant plasmid p15D.

(34) In addition, PCR was performed with DNA (SEQ ID NO: 5) of 2,4-diaminobutanoate decarboxylase (ddc) derived from Acinetobacter baumannii ATCC 19606 strain as a template, and primers of SEQ ID NOs: 11 and 12 under the same condition as described above, thereby producing a ddc gene fragment.

(35) Next, the ddc gene fragment and the p15D plasmid were treated with restriction enzymes (KpnI and PstI), and then, treated with T4 DNA ligase to bind the ddc fragment and the p15D plasmid cut with the restriction enzymes, thereby constructing a recombinant plasmid p15DD (FIG. 2).

(36) 1-2: Construction of p15DD.sup.opt Vector Containing dat.sup.opt and ddc.sup.opt

(37) In order to increase expression in E. coli of 2-ketoglutarate 4-aminotransferase derived from the Acinetobacter baumannii ATCC 19606 strain, dat.sup.opt gene (SEQ ID NO: 4) optimized in codon of E. coli was synthesized by Bioneer Corporation (Daej eon, Korea), and was provided in a pGEM-B1-dat.sup.opt plasmid form. PCR was performed with dat.sup.opt gene in the pGEM-B1-dat.sup.opt plasmid as a template, and primers of SEQ ID NOs: 9 and 10 under the same condition as Example 1-1, thereby producing a dat.sup.opt gene fragment.

(38) Next, the dat.sup.opt fragment and a pTac15k plasmid (p15A origin, low copies, Km.sup.R, KAISTMBEL labstock) performing strong gene expression with a tac promoter were treated with restriction enzymes (EcoRI and KpnI), and treated with T4 DNA ligase to bind the dat.sup.opt fragment and the pTac15k plasmid cut with the restriction enzymes, thereby constructing a recombinant plasmid p15D.sup.opt.

(39) In addition, in order to increase expression in E. coli of 2,4-diaminobutanoate decarboxylase derived from the Acinetobacter baumannii ATCC 19606 strain, dde.sup.opt gene (SEQ ID NO: 6) optimized in codon of E. coli was synthesized by Bioneer Corporation (Daej eon, Korea), and was provided in a pGEM-B1-ddc.sup.opt plasmid form. PCR was performed with dde.sup.opt gene in the pGEM-B1-dde.sup.opt plasmid as a template, and primers of SEQ ID NOs: 11 and 12 under the same condition as Example 1-1, thereby producing a dde.sup.opt gene fragment.

(40) Next, the dde.sup.opt gene fragment and the p15D.sup.opt plasmid were treated with restriction enzymes (KpnI and PstI), and then, treated with T4 DNA ligase to bind the dde.sup.opt fragment and the p15D.sup.opt plasmid cut with the restriction enzymes, thereby constructing a recombinant plasmid p15DD.sup.opt (FIG. 3).

(41) 1-3: Construction of p15DD.sup.optppc Vector

(42) In order to improve the production capacity of the 1,3-diaminopropane by increasing pool of oxaloacetate (OAA), PCR was performed with DNA (SEQ ID NO: 7) of the gene (ppc) encoding phosphoenolpyruvate carboxylase derived from E. coli W3110 and converting phosphoenolpyruvate (PEP) into OAA as a template, and primers of SEQ ID NOs: 13 and 14 under the same condition as Example 1-1, thereby producing a ppc gene fragment. Further, PCR was performed with the p15DD.sup.opt vector produced in Example 1-2 as a template, and primers of SEQ ID NOs: 15 and 16 under the same condition as Example 1-1, thereby producing a fragment of the 15DD.sup.opt plasmid.

(43) Next, the ppc gene fragment was bound to the fragment of the p15DD.sup.opt plasmid by a Gibson assembly method (Gibson et al., Nat. Methods 6:343-341, 2009), thereby constructing a recombinant plasmid, p15DD.sup.optppc (FIG. 4).

(44) 1-4: Construction of p15DD.sup.optpaspC Vector

(45) In order to improve the production capacity of the 1,3-diaminopropane by increasing pool of aspartate (L-ASP), PCR was performed with DNA (SEQ ID NO: 8) of the gene (aspC) encoding aspartate aminotransferase derived from E. coli W3110 and converting OAA into L-ASP as a template, and primers of SEQ ID NOs: 17 and 18 under the same condition as Example 1-1, thereby producing an aspC gene fragment. Further, PCR was performed with the p15DD.sup.opt vector produced in Example 1-2 as a template, and primers of SEQ ID NOs: 15 and 16 under the same condition as Example 1-1, thereby producing a fragment of the p15DD.sup.opt plasmid.

(46) Next, the aspC gene fragment was bound to the fragment of the p15DD.sup.opt plasmid by the Gibson assembly method (Gibson et al., Nat. Methods 6:343-341, 2009), thereby constructing a recombinant plasmid, p15DD.sup.optaspC. Further, in order to increase expression of the aspC, a tac promoter fragment was amplified by performing PCR with pTac15k as a template and primers of SEQ ID NOs: 19 and 20 under the same condition as Example 1-1, and a fragment of p15DD.sup.optapsC plasmid was produced by performing PCR with the p15DD.sup.optaspC plasmid as a template and primers of SEQ ID NOs: 15 and 21 under the same condition as Example 1-1. Then, the tac promoter fragment was bound to the fragment of p15DD.sup.optapsC plasmid by the Gibson assembly method reported in the art, and p15DD.sup.optpaspC was finally constructed (FIG. 5).

EXAMPLE 2

Construction of Recombinant Microorganism Containing Recombinant Plasmid and Production of 1,3-Diaminopropane Using the Same

(47) 2-1: Construction of WL3110/p15DD Strain

(48) A WL3110/p15DD strain was produced by introducing the p15DD vector produced in Example 1-1 into a WL3110 (W3110 lacI) strain produced by the method known in Korean Patent Laid-Open Publication No. 10-2009-0018781. Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism.

(49) 2-2: Construction of WL3110/p15DD.sup.opt Strain

(50) A WL3110/p15DD.sup.opt strain was produced by introducing the p15DD.sup.opt vector produced in Example 1-2 into a WL3110 (W3110 lacI) strain. Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism.

(51) 2-3: Construction of TH02/p15DD Strain

(52) A TH02/p15DD strain was produced by introducing the p15DD vector produced in Example 1-1 into a TH02 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T) wherein the TH02 strain was obtained by mutating C of 1034.sup.th sequence of the gene encoding aspartokinase I with T and mutating C of 1055.sup.th sequence of the gene encoding aspartokinase III with T in the WL3110 strain (W3110 lacI). Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism

(53) 2-4: Construction of TH02/p15DD.sup.opt Strain

(54) A TH02/p15DD.sup.opt strain was produced by introducing the p15DD.sup.opt vector produced in Example 1-2 into the TH02 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T) produced in Example 2-3. Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism.

(55) 2-5: Construction of DP01/p15DD.sup.opt Strain

(56) A DP01/p15DD.sup.opt strain was produced by introducing the p15DD.sup.opt vector produced in Example 1-2 into a DP01 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T Pppc::Ptrc), wherein the DP01 strain was obtained by substituting the promoter of ppc with trc in the TH02 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T) of Example 2-3. Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism.

(57) 2-6: Construction of DP02/p15DD.sup.opt Strain

(58) A DP02/p15DD.sup.opt strain was produced by introducing the p15DD.sup.opt vector produced in Example 1-2 into a DP02 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T Pppc::Ptrc PaspC::Ptrc), wherein the DP02 strain was obtained by substituting the promoter of aspC with trc in the DP01 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T Pppc::Ptrc) of Example 2-5. Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism.

(59) 2-7: Construction of DP09/p15DD.sup.opt Strain

(60) A DP09/p15DD.sup.opt strain was produced by introducing the p15DD.sup.opt vector produced in Example 1-2 into a DP09 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T Pppc::Ptrc PaspC::Ptrc pfkA), wherein the DP09 strain was obtained by deleting pfkA from the DP02 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T Pppc::Ptrc PaspC::Ptrc) of Example 2-6. Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism.

(61) 2-8: Construction of DP09/p15DD.sup.opt Strain

(62) A DP09/p15DD.sup.optppc strain was produced by introducing the p15DD.sup.optppc vector produced in Example 1-3 into the DP09 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T Pppc::Ptrc PaspC::Ptrc pfkA) of Example 2-7. Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism.

(63) 2-9: Construction of DP09/p15DD.sup.optpaspC Strain

(64) A DP09/p15DD.sup.optpaspC strain was produced by introducing the p15DD.sup.optpaspC vector produced in Example 1-4 into the DP09 strain (W3110 lacI thr.sup.AC1034TlysC.sup.C1055T Pppc::Ptrc PaspC::Ptrc pfkA) of Example 2-7. Then, the produced strain was inoculated into an LB plate medium containing 25 mg/L of kanamycin, and cultured for 16 hours at 37 C. to select the recombinant microorganism.

(65) 2-10: Production of 1,3-Diaminopropane Using Recombinant Microorganism

(66) In order to confirm the production capacity of 1,3-diaminopropane of the recombinant microorganism, the strains of Examples 2-1 to 2-9 and Control strains (WL3110 and WL3110/pTac15k) were inoculated into an LB medium (10 mL), and pre-cultured for 8 hours at 37 C. Then, the pre-cultured culture fluid (1.5 mL) was inoculated into a 350 mL flask containing R/2 medium (30 mL). The R/2 medium consisted of 10 g glucose, 2 g (NH.sub.4).sub.2HPO.sub.4, 6.75 g KH.sub.2PO.sub.4, 0.85 g citric acid, 0.8 g MgSO.sub.4.7H.sub.2O, 3 g (NH.sub.4).sub.2SO.sub.4, and 5 mL trace metal solution per 1 L distilled water, and the trace metal solution contained 5 M HCl: 10 g FeSO.sub.4.7H.sub.2O, 2.25 g ZnSO.sub.4.7H.sub.2O, 1 g CuSO.sub.4.5H.sub.2O, 0.5 g MnSO.sub.4.5H.sub.2O, 0.23 g Na.sub.2B.sub.4O.sub.7.10H.sub.2O, 2 g CaCl.sub.2.2H.sub.2O, and 0.1 g (NH.sub.4).sub.6MO.sub.7O.sub.24 per 1 L. The culturing was conducted by a shaking incubator (jSR, Korea) operating at 200 rpm for 36 hours at 37 C. After the culturing, a culture fluid was subjected to centrifugation at 13,200 rpm for 10 minutes by using a centrifuge, and the supernatant was collected to measure concentration of 1,3-diaminopropane through high performance liquid chromatography (HPLC) analysis.

(67) As a result, as shown in Table 1 below, it could be confirmed that respective recombinant microorganisms produced different concentrations of 1,3-aminopropane.

(68) TABLE-US-00001 TABLE 1 Strain 1,3-Diaminopropane concentration (mg/L) WL3110 0 WL3110/pTac15k 0 WL3110/p15DD 65 WL3110/p15DD.sup.opt 144 TH02/p15DD 89 TH02/p15DD.sup.opt 175 DP01/p15DD.sup.opt 182 DP02/p15DD.sup.opt 282 DP09/p15DD.sup.opt 680 DP09/p15DD.sup.optppc 1391 DP09/p15DD.sup.optpaspC 1349

(69) When the recombinant microorganism producing the 1,3-diaminopropane according to the present disclosure is used, 1,3-diaminopropane may be mass-produced to be industrially useful in various fields such as pharmaceutical products, agricultural products, fibers for clothing, etc.

(70) Although specific embodiments of the present disclosure are described in detail, it will be apparent to those skilled in the art that the specific description is merely desirable exemplary embodiment and should not be construed as limiting the scope of the present disclosure. Therefore, the substantial scope of the present disclosure is defined by the accompanying claims and equivalent thereof.